Author:
Knapp F. F.,Dash Ashutosh
Reference47 articles.
1. Ahlskog J, Paganelli G, Neri D. Vascular tumor targeting. Q J Nucl Med Mol Imaging. 2006;50:296–309.
2. Anand P, Kunnumakara AB, Sundaram C. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008;25(9):2097–116.
3. Azinovic I, DeNardo GL, Lamborn KR, et al. Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies. Cancer Immunol Immunother. 2006;55:1451–8.
4. Barendswaard EC, Humm JL, O’Donoghue JA. Therapeutic efficacy of 125I- and 131I-labeled monoclonal antibody A33 in a human colon cancer xenograft. J Nucl Med. 2001;42:1251–6.
5. Baxevanis CN, Perez SA, Papamichail M. Cancer immunotherapy. Crit Rev Clin Lab Sci. 2009;46(4):167–89.